Show simple item record

dc.contributor.authorRojas Torres, Marta 
dc.contributor.authorBeltrán Camacho, Lucía 
dc.contributor.authorMartínez Val, Ana
dc.contributor.authorSánchez Gomar, Ismael 
dc.contributor.authorEslava Alcón, Sara 
dc.contributor.authorRosal Vela, Antonio 
dc.contributor.authorJiménez Palomares, Margarita 
dc.contributor.authorDoiz Artázcoz, Esther 
dc.contributor.authorMartínez-Torija, Mario
dc.contributor.authorMoreno-Luna, Rafael
dc.contributor.authorOlsen, Jesper V.
dc.contributor.authorDurán Ruiz, María del Carmen 
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.contributor.otherCirugíaes_ES
dc.date.accessioned2025-03-05T08:40:53Z
dc.date.available2025-03-05T08:40:53Z
dc.date.issued2024-07-15
dc.identifier.issn1423-0127
dc.identifier.issn1021-7770
dc.identifier.urihttp://hdl.handle.net/10498/35703
dc.description.abstractAbstract Background Critical limb-threatening ischemia (CLTI) constitutes the most severe manifestation of peripheral artery disease, usually induced by atherosclerosis. CLTI patients suffer from high risk of amputation of the lower extremities and elevated mortality rates, while they have low options for surgical revascularization due to associated comorbidities. Alternatively, cell-based therapeutic strategies represent an effective and safe approach to promote revascularization. However, the variability seen in several factors such as cell combinations or doses applied, have limited their success in clinical trials, being necessary to reach a consensus regarding the optimal “cellular-cocktail” prior further application into the clinic. To achieve so, it is essential to understand the mechanisms by which these cells exert their regenerative properties. Herein, we have evaluated, for the first time, the regenerative and vasculogenic potential of a combination of endothelial colony forming cells (ECFCs) and mesenchymal stem cells (MSCs) isolated from adipose-tissue (AT), compared with ECFCs from umbilical cord blood (CB-ECFCs) and AT-MSCs, in a murine model of CLTI. Methods Balb-c nude mice (n:32) were distributed in four different groups (n:8/group): control shams, and ischemic mice (after femoral ligation) that received 50 μl of physiological serum alone or a cellular combination of ATMSCs with either CB-ECFCs or AT-ECFCs. Follow-up of blood flow reperfusion and ischemic symptoms was carried out for 21 days, when mice were sacrificed to evaluate vascular density formation. Moreover, the long-term molecular changes in response to CLTI and both cell combinations were analyzed in a proteomic quantitative approach. Results AT-MSCs with either AT- or CB-ECFCs, promoted a significant recovery of blood flow in CLTI mice 21 days post-ischemia. Besides, they modulated the inflammatory and necrotic related processes, although the CB groupes_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceJournal of Biomedical Science, Vol. 31, Núm. 1, 2024es_ES
dc.titleUnraveling the differential mechanisms of revascularization promoted by MSCs & ECFCs from adipose tissue or umbilical cord in a murine model of critical limb-threatening ischemiaes_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1186/S12929-024-01059-W
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/823839/EU es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI//PID2022-137080OB-I00es_ES
dc.type.hasVersionVoRes_ES


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
This work is under a Creative Commons License Atribución 4.0 Internacional